Found

About Found

Found differentiates itself through a science-forward approach anchored by their proprietary MetabolicPrint assessment — a personalized metabolic profiling tool that aims to match patients with the most effective medication and lifestyle plan for their individual biology. Founded in 2020, the platform combines this personalization with a comprehensive clinical program.

The medication menu spans both brand-name options (Ozempic, Wegovy, Zepbound, Mounjaro) and compounded alternatives, with monthly pricing from $149 to $399. Insurance is accepted, and the platform maintains high cost transparency throughout. The MetabolicPrint assessment gives Found a clinical angle that most competitors lack — rather than a one-size-fits-all approach, the goal is data-driven treatment matching.

Clinically, Found earns perfect marks for provider quality and support. Lab testing and dietitian access are both included, and the holistic approach integrates medication with behavioral and nutritional guidance. This is the kind of comprehensive care model that produces better long-term outcomes — medication alone typically results in weight regain when discontinued.

Reputation is solid but not exceptional: a 3.6 Trustpilot rating across 660+ reviews combined with an A+ BBB rating. The Trustpilot score suggests some patients experience friction — likely around communication or billing — while the A+ BBB indicates strong business practices and complaint resolution.

Moderate onboarding speed is the main trade-off for the thorough intake process, which includes the MetabolicPrint assessment. Patients prioritizing speed over depth may find this slower than telehealth-native competitors.

Found GLP-1 Medications

At a Glance